Featured Research

from universities, journals, and other organizations

Hi-Tech Initiative in Quest for Better Drugs

Date:
November 30, 2006
Source:
University of Edinburgh
Summary:
Breast cancer sufferers could eventually benefit from high-tuned, tailor-made drug treatments that minimize side effects as a result of a joint initiative between computer scientists in Edinburgh and cellular biologists in Japan.

Igor Goryanin, director of the Edinburgh Centre for Bioinformatics and Dr. Yoshiyuki Sakaki, head of Riken Genomic Research Centre.
Credit: Image courtesy of University of Edinburgh

Breast cancer sufferers could eventually benefit from high-tuned, tailor-made drug treatments that minimise side effects as a result of a joint initiative between computer scientists in Edinburgh and cellular biologists in Japan.

The five-year project, which involves the University of Edinburgh and the Riken Genomic Research Centre in Japan, will initially look at why particular treatments for breast cancer work in some patients and not in others.

It will use advanced computer systems set up at the University of Edinburgh's School of Informatics to run programmes incorporating expertise from cellular biologists in Japan to better understand the make-up of particular drugs and why their effectiveness differs among patients.

It is hoped that the database, which will use clinical information from patients at the Edinburgh Breast Unit and Cancer Research Centre, will be able to narrow down the different types of drugs that should be prescribed to individual patients and what types of combination therapy would have the best outcome.

The database could also provide information for creating new drugs, with computer modelling becoming an integral part of medical research.

Igor Goryanin, director of the Edinburgh Centre for Bioinformatics, based at the University, said: "The computer systems will help the biologist to understand the function of the organisms and, with this knowledge, we will be able to predict more accurately which new and existing drugs work and why.

"We would hope to further our research further and look at other cancers as well as diseases such as heart disease and neural and psychiatric diseases. Identifying which drugs have the best responses in particular patients would not only save lives but would also save the NHS money as treatment with expensive drugs can be tailor-made for whom it works."


Story Source:

The above story is based on materials provided by University of Edinburgh. Note: Materials may be edited for content and length.


Cite This Page:

University of Edinburgh. "Hi-Tech Initiative in Quest for Better Drugs." ScienceDaily. ScienceDaily, 30 November 2006. <www.sciencedaily.com/releases/2006/11/061128084335.htm>.
University of Edinburgh. (2006, November 30). Hi-Tech Initiative in Quest for Better Drugs. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2006/11/061128084335.htm
University of Edinburgh. "Hi-Tech Initiative in Quest for Better Drugs." ScienceDaily. www.sciencedaily.com/releases/2006/11/061128084335.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins